Literature DB >> 9449664

Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice.

D E Clouthier1, K Hosoda, J A Richardson, S C Williams, H Yanagisawa, T Kuwaki, M Kumada, R E Hammer, M Yanagisawa.   

Abstract

Neural crest cells arise in the dorsal aspect of the neural tube and migrate extensively to differentiate into a variety of neural and non-neural tissues. While interactions between neural crest cells and their local environments are required for the proper development of these tissues, little information is available about the molecular nature of the cell-cell interactions in cephalic neural crest development. Here we demonstrate that mice deficient for one type of endothelin receptor, ETA, mimic the human conditions collectively termed CATCH 22 or velocardiofacial syndrome, which include severe craniofacial deformities and defects in the cardiovascular outflow tract. We show that ETA receptor mRNA is expressed by the neural crest-derived ectomesenchymal cells of pharyngeal arches and cardiac outflow tissues, whereas ET-1 ligand mRNA is expressed by arch epithelium, paraxial mesoderm-derived arch core and the arch vessel endothelium. This suggests that paracrine interaction between neural crest-derived cells and both ectoderm and mesoderm is essential in forming the skeleton and connective tissue of the head. Further, we find that pharyngeal arch expression of goosecoid is absent in ETA receptor-deficient mice, placing the transcription factor as one of the possible downstream signals triggered by activation of the ETA receptor. These observations define a novel genetic pathway for inductive communication between cephalic neural crest cells and their environmental counterparts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9449664     DOI: 10.1242/dev.125.5.813

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  160 in total

Review 1.  Neural crest patterning and the evolution of the jaw.

Authors:  C B Kimmel; C T Miller; R J Keynes
Journal:  J Anat       Date:  2001 Jul-Aug       Impact factor: 2.610

2.  Endothelin B receptor is not required but necessary for finite regulation of ovulation.

Authors:  Jongki Cho; Heyyoung Kim; Dong-Wook Kang; Masashi Yanagisawa; CheMyong Ko
Journal:  Life Sci       Date:  2012-03-03       Impact factor: 5.037

Review 3.  Building a heart: implications for congenital heart disease.

Authors:  Deepak Srivastava
Journal:  J Nucl Cardiol       Date:  2003 Jan-Feb       Impact factor: 5.952

Review 4.  Combinatorial transcriptional interaction within the cardiac neural crest: a pair of HANDs in heart formation.

Authors:  Anthony B Firulli; Simon J Conway
Journal:  Birth Defects Res C Embryo Today       Date:  2004-06

5.  Alcama mediates Edn1 signaling during zebrafish cartilage morphogenesis.

Authors:  Priya Choudhry; Deepa Joshi; Birgit Funke; Nikolaus Trede
Journal:  Dev Biol       Date:  2010-11-10       Impact factor: 3.582

Review 6.  Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?

Authors:  L E Spieker; G Noll; F T Ruschitzka; T F Lüscher
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

7.  Molecular characterization of two endothelin pathways in East African cichlid fishes.

Authors:  Eveline T Diepeveen; Walter Salzburger
Journal:  J Mol Evol       Date:  2012-01-21       Impact factor: 2.395

8.  Cre recombinase-regulated Endothelin1 transgenic mouse lines: novel tools for analysis of embryonic and adult disorders.

Authors:  Andre L P Tavares; David E Clouthier
Journal:  Dev Biol       Date:  2015-02-25       Impact factor: 3.582

Review 9.  Role of endothelin-1 in hypertension.

Authors:  Marc Iglarz; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

10.  mef2ca is required in cranial neural crest to effect Endothelin1 signaling in zebrafish.

Authors:  Craig T Miller; Mary E Swartz; Patricia A Khuu; Macie B Walker; Johann K Eberhart; Charles B Kimmel
Journal:  Dev Biol       Date:  2007-05-24       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.